Cannabis and COVID-19: How a Federally Illegal Drug Continues to Exist as an “Essential Business” at the State Level
When: April 24, 2020
Conference:
American Bar Association
Webinar
People: Noelle K. Sheehan

Noelle Sheehan (Of Counsel-Orlando) and Neil Willner (Associate-White Plains) will join Andrew Kline, Policy Director for the National Cannabis Industry Association, Kelly Fair, the U.S. General Counsel for Canopy Growth Corporation, and Sal Barnes, Managing Director of MPG Consulting, for the ABA webinar, “Cannabis and COVID-19: How a Federally Illegal Drug Continues to Exist as an ‘Essential Business’ at the State Level” on April 24, 2020. Noelle and Neil will discuss how COVID-19 is affecting the legal and cannabis industries in more ways than you might think. For example, the pandemic has upended legalization efforts, the lack of viable business interruption insurance could be a death knell for small cannabis operators, the long-term implications of COVID-19 on the cannabis industry, the differences between hemp and marijuana and what that means under the CARES Act, and the impact cannabis municipal bonds could have on states.

More information and registration are available on the event website.